A memorandum of understanding has been signed to implement a wide-ranging sickle cell anaemia screening project in Jharkhand. This collaboration aims to establish a testing hub to facilitate ...

People with sickle cell disease are immunocompromised, which means they have an increased risk of infection. For this reason, immunizations are an important part of complete sickle cell care. This ...

WASHINGTON (AP) — The U.S. government is facing a generational realignment as President Donald Trump directs federal agencies to develop plans for eliminating employee positions and ...

WASHINGTON (AP) — The Trump administration is creating a registry for all people who are in the United States illegally, and those who don’t self-report could face fines or prosecution ...

LANSING, Mich. (Gray News) – A Republican representative from Michigan said he plans to introduce a resolution urging the United States Supreme Court to overturn the 2015 court case ruling that ...

NEW HAVEN, Conn. (WTNH) — News 8 is once again honoring Black history by looking at health care and the racial disparities many report facing. According to the Pew Research Center, overall, 18% ...

PASIG CITY, 13 February 2025 – Echoing the position of President Ferdinand R. Marcos Jr., the Department of Education (DepEd) has reaffirmed its commitment to sustaining key education initiatives ...

If you missed Patch 01.002.103 dropping, it addressed the LAS-17 Double-Edge Sickle and the GP-31 Ultimatum from the Servants of Freedom warbond having arrived with "the wrong versions of some files".

As outlined in the notes for Patch 01.002.103, Arrowhead accidentally shipped the LAS-17 Double-Edge Sickle and the GP-31 Ultimatum with "the wrong versions of some files". So, it's rectified that ...

A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease. Casgevy, also known as exa-cel, was the first treatment to be licensed using gene-editing ...

A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England. About 50 people a year with the inherited blood disorder are likely to ...